Valone F H, Johnson B
Veterans Administration Medical Center, Cancer Research Institute, San Francisco, CA 94121.
Biochem J. 1987 Nov 1;247(3):669-74. doi: 10.1042/bj2470669.
The mechanisms by which platelet-activating factor (PAF) and thrombin increase intracellular calcium were examined. Platelets were loaded with the calcium-sensitive fluorescent probe Quin 2 and then were suspended in buffer containing 0.5 mM-Mn2+ in order to quantify simultaneously calcium release from intracellular stores and divalent cation influx. Pretreating platelets with agents which activate protein kinase C [the phorbol ester phorbol myristate acetate (PMA) or the diacylglycerol 1-oleoyl-2-acetylglycerol (OAG)] inhibited increased intracellular calcium by PAF and thrombin in a dose-related manner. That protein kinase C regulates intracellular calcium by phosphorylating proteins in two distinct pathways was suggested by two observations. PAF-induced calcium release was more sensitive to inhibition by PMA and OAG than was manganese influx and the kinetics of recovery from inhibition were different for the two pathways. Both PMA and OAG aggregated Quin 2-loaded platelets without eliciting measurable increases in intracellular calcium. In contrast, prostacyclin, which increases intracellular cyclic AMP, inhibited calcium release and influx in parallel, suggesting that this agent acts at a step common to both pathways.
研究了血小板活化因子(PAF)和凝血酶增加细胞内钙的机制。用钙敏感荧光探针喹啉2加载血小板,然后将其悬浮在含有0.5 mM - Mn2+的缓冲液中,以便同时定量细胞内钙库的钙释放和二价阳离子内流。用激活蛋白激酶C的试剂(佛波酯肉豆蔻酸佛波醇酯(PMA)或二酰基甘油1-油酰基-2-乙酰甘油(OAG))预处理血小板,可剂量相关地抑制PAF和凝血酶引起的细胞内钙增加。两项观察结果提示蛋白激酶C通过两条不同途径使蛋白质磷酸化来调节细胞内钙。PAF诱导的钙释放比锰内流对PMA和OAG的抑制更敏感,并且两条途径从抑制中恢复的动力学不同。PMA和OAG均可使加载喹啉2的血小板聚集,但未引起细胞内钙的可测量增加。相反,增加细胞内环磷酸腺苷(cAMP)的前列环素可同时抑制钙释放和内流,表明该试剂作用于两条途径的共同步骤。